Molbio Diagnostics shares surged 20% on September 10, 2026, reaching an all-time high of ₹1,509.70. The company reported a profit of ₹52.74 crore for Q1 FY27 and a sharp increase in Truenat test-kit volumes, reinforcing its strong market position and optimistic future outlook.
Molbio Diagnostics share price hits 20% upper circuit, jumps 87% from IPO price
Molbio Diagnostics shares surged 20% on September 10, 2026, reaching an all-time high of ₹1,509.70. The company reported...
By Dhallo News · September 10, 2026 at 12:20 PM IST

Source: Mint - Markets
Have feedback on this article?Report error or suggestion
